Stockreport

Cue Biopharma beats on revenue [Seeking Alpha]

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF Cue Biopharma (NASDAQ: CUE ): Q3 GAAP EPS of -$0.62. Revenue of $0.45M . 10-Q [Read more]